RA
Rajat Agrawal
About Rajat Agrawal
Data last updated:
Rajat Agrawal is a Director at Dlrc Infraheight Private Limited (since 2014), Director at Aarogena Farmaceuticals Private Limited (since 2025) and Director at D.L.R.C. Bio-Tech Private Limited (since 2020). The companies operate in Real Estate, Agriculture and Oil & Gas. The largest current company by reported revenue is Dlrc Infraheight Private Limited at ₹65.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Feb 2014 | 2006 | ₹65.5 Lakh (FY 2025) | Active | |
| Director | 09 Jun 2025 | 2025 | Active | ||
| Director | 21 Aug 2020 | 2020 | Active |
Board colleagues of Rajat Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandan Agrawal | 06834043 | Dlrc Infraheight Private Limited , D.L.R.C. Bio-Tech Private Limited | Director |
| Ashu Gaur | 08108291 | Aarogena Farmaceuticals Private Limited | Director |
| Deeksha Agrawal | 11145357 | Aarogena Farmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajat Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajat Agrawal
Rajat Agrawal currently holds 3 directorships: Dlrc Infraheight Private Limited (Director, since 10 Feb 2014, revenue ₹65.5 Lakh (FY 2025)); Aarogena Farmaceuticals Private Limited (Director, since 09 Jun 2025); D.L.R.C. Bio-Tech Private Limited (Director, since 21 Aug 2020).
Rajat Agrawal was first appointed on 10 Feb 2014 as Director at Dlrc Infraheight Private Limited. The most recent appointment on record is 09 Jun 2025 at Aarogena Farmaceuticals Private Limited.
The current boards of Rajat Agrawal's companies include Chandan Agrawal (Dlrc Infraheight Private Limited), Ashu Gaur (Aarogena Farmaceuticals Private Limited), Deeksha Agrawal (Aarogena Farmaceuticals Private Limited).